NASDAQ : SKIN

SkinHealth Systems Inc.

$0.8393 USD

-$0.07 (-7.35%)

Volume
501.01K
Average Volume
2.82M
Market Capitalization
$108.77M
P/E Ratio
-15.12
Dividend Yield
0.00%
Price Target
$1.50
Year High
$2.69
Year Low
$0.55
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.79
Source Headline
SkinHealth Systems Inc. (SKIN) Upgraded to Strong Buy: Here's Why

SkinHealth Systems Inc. (SKIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com - 2026-07-14 13:01:09

SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types

SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars

globenewswire.com - 2026-07-07 08:05:00

Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair

globenewswire.com - 2026-06-02 08:05:00

Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention

Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

zacks.com - 2026-05-12 10:15:26

Beauty Health Q1 Earnings Call Highlights

Beauty Health NASDAQ: SKIN, referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year over year to $8.5 million, exceeding the high end of its guidance range.

marketbeat.com - 2026-05-08 22:07:00

SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript

SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-08 02:41:15

SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates

SkinHealth Systems Inc. (SKIN) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.08 per share a year ago.

zacks.com - 2026-05-07 20:11:34

Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics

The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-05-07 19:30:24

SkinHealth Systems Reports First Quarter 2026 Financial Results

LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 (“Q1 2026”).

globenewswire.com - 2026-05-07 16:05:00

SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

SkinHealth Systems Inc. (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-30 11:01:29

The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients' healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to sup.

businesswire.com - 2026-04-29 16:30:00

SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026.

globenewswire.com - 2026-04-29 10:00:00

SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the “Board”): Mr.

globenewswire.com - 2026-04-22 16:05:00

The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform

LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) today announced a corporate rebrand to SkinHealth Systems Inc., marking its evolution into a clinically driven, science-backed medical aesthetics company.

globenewswire.com - 2026-04-22 08:00:00

Get SKIN Insider Trade Alerts

SKIN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$1.50

2 analysts

Last Year

$2.03

4 analysts

All Time

$4.30

11 analysts

SKIN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-05-20 Roth Capital Maintain Buy Buy
2026-05-01 Canaccord Genuity Maintain Hold Hold
2026-03-16 TD Cowen Maintain Hold Hold
2026-03-13 Canaccord Genuity Maintain Hold Hold
2026-01-21 TD Cowen Maintain Hold Hold
2025-09-22 TD Cowen Maintain Hold Hold
2025-08-01 Stifel Maintain Hold Hold
2025-05-05 Canaccord Genuity Maintain Hold Hold
2025-03-13 Canaccord Genuity Maintain Hold Hold
2024-11-13 Canaccord Genuity Maintain Hold Hold
2024-08-12 Canaccord Genuity Maintain Hold Hold
2024-08-09 Piper Sandler Maintain Underweight Underweight
2024-07-26 Stifel Maintain Hold Hold
2024-07-11 Piper Sandler Maintain Underweight Underweight
2024-05-13 DA Davidson Maintain Buy Buy
2024-05-13 TD Cowen Maintain Hold Hold
2024-05-10 Piper Sandler Maintain Underweight Underweight
2024-03-15 DA Davidson Maintain Buy Buy
2024-03-14 Canaccord Genuity Maintain Hold Hold
2024-03-13 Piper Sandler Maintain Underweight Underweight
2024-03-13 TD Cowen Maintain Market Perform Market Perform
2024-03-13 Stifel Maintain Hold Hold
2024-02-29 Canaccord Genuity Maintain Hold Hold
2023-11-15 Jefferies Downgrade Buy Hold
2023-11-14 Raymond James Downgrade Market Perform Underperform
2023-11-14 Canaccord Genuity Downgrade Buy Hold
2023-11-14 Benchmark Downgrade Buy Hold
2023-11-14 Stifel Maintain Hold Hold
2023-11-14 JP Morgan Downgrade Neutral Underweight
2023-11-14 Piper Sandler Downgrade Overweight Underweight
2023-11-14 TD Cowen Downgrade Outperform Market Perform
2023-11-14 William Blair Downgrade Outperform Market Perform
2023-09-13 Benchmark Maintain Buy Buy
2023-08-10 TD Cowen Maintain Outperform Outperform
2023-08-10 DA Davidson Maintain Buy Buy
2023-08-08 Benchmark Maintain Buy Buy
2023-06-21 Stifel Downgrade Buy Hold
2023-05-26 JP Morgan Maintain Neutral Neutral
2023-05-18 Benchmark Maintain Buy Buy
2023-05-11 DA Davidson Maintain Buy Buy
2023-03-28 Canaccord Genuity Maintain Buy Buy
2023-03-20 Exane BNP Paribas Upgrade Underperform Neutral
2023-03-14 Benchmark Maintain Buy Buy
2023-03-01 DA Davidson Maintain Buy Buy
2023-02-16 Cowen & Co. Maintain Outperform Outperform
2022-11-23 Goldman Sachs Maintain Buy Buy
2022-11-09 DA Davidson Maintain Buy Buy
2022-11-09 JP Morgan Downgrade Overweight Neutral
2022-09-28 DA Davidson Maintain Buy Buy
2022-09-16 DA Davidson Maintain Buy Buy
2022-09-16 Piper Sandler Maintain Overweight Overweight
2022-08-16 Goldman Sachs Maintain Buy Buy
2022-08-10 Piper Sandler Maintain Overweight Overweight
2022-08-10 DA Davidson Maintain Buy Buy
2022-07-08 Piper Sandler Maintain Overweight Overweight
2022-06-30 Canaccord Genuity Maintain Buy Buy
2022-05-12 DA Davidson Maintain Buy Buy
2022-05-11 Piper Sandler Maintain Overweight Overweight
2022-05-11 Goldman Sachs Maintain Buy Buy
2022-04-28 Piper Sandler Maintain Overweight Overweight
2022-03-14 Benchmark Maintain Buy Buy
2022-03-11 JP Morgan Maintain Overweight Overweight
2022-02-23 DA Davidson Maintain Buy Buy
2022-01-07 William Blair Maintain Outperform Outperform
2021-12-23 Raymond James Maintain Market Perform Perform
2021-11-10 DA Davidson Maintain Buy Buy
2021-10-08 Stifel Maintain Buy Buy
2021-10-04 Cowen & Co. Maintain Outperform Outperform
2021-08-11 DA Davidson Maintain Buy Buy
2021-07-19 Jefferies Maintain Buy Buy
2021-07-01 Goldman Sachs Maintain Buy Buy
2021-06-24 Piper Sandler Maintain Overweight Overweight
2021-06-15 Canaccord Genuity Maintain Buy Buy
2021-06-01 DA Davidson Maintain Buy Buy